Search
for
Sort by
Research 121–150 of 348
- Repurposing Metformin for Dermatological Use: Mechanisms, Evidence, and Clinical Perspectives
- Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma
- B-Raf and C-Raf Are Required for Melanocyte Stem Cell Self-Maintenance
- Network pharmacology and molecular docking analysis on potential molecular targets and mechanism of action of BRAF inhibitors for application in wound healing
- The risk of dermatological toxicities of combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma patients: a systematic review and meta-analysis
- Melanotic pigmentation in excisional scar of melanoma patient who received BRAF and MEK inhibitors
- Abstract 1677: Epithelial hyperplasia induced by a selective B-Raf inhibitor, WYE-130600
- 554 Repurposing a clinical antimalarial for the therapeutic induction of lethal ER stress targeting BRAF-kinase inhibitor-resistant malignant melanoma
- 696 MEK and BRAF inhibitors augment the production and accumulation of sebum in hamster sebocytes
- Melanocytes: The new Black
- Hair and nail adverse events during treatment with targeted therapies for metastatic melanoma
- Cutaneous Drug Eruptions Associated with the Use of New Oncological Drugs
- Cutaneous toxicities of new treatments for melanoma
- The spectrum of cutaneous adverse events during encorafenib and binimetinib treatment in B‐rapidly accelerated fibrosarcoma‐mutated advanced melanoma
- Management of Dermatologic Toxicities
- Vemurafenib-induced pityriasis amiantacea: a case report
- Diseases of the Canine Prostate Gland
- The Influence of Flightless I: Regeneration versus Wound Healing
- Alopecia due to chemotherapeutics, hedgehog inhibitors, targeted antibody therapies and immune checkpoint inhibitors
- Inflammatory and non-melanocytic tumoral pathology of the nail
- Tombo em João Pessoa dá força a Memorial da Arquitetura Paraibana
- Regulation of melanocyte stem cell behavior by the niche microenvironment
- Exploiting the origins of Ras mediated squamous cell carcinoma to develop novel therapeutic interventions
- Targeted therapy in melanoma
- Genetics of thyroid lesions updated
- Progress in Dermatology and Venereology in 2023 as reflected in the Journal of the European Academy of Dermatology and Venereology
- LB1031 Immune Cell-Mediated Amplification of Stem Cell Activation in Hairy Melanocytic Nevus via Osteopontin-CD44 Axis
- Sorafenib combined with hepatectomy in patients with intermediate-stage and advanced hepatocellular carcinoma
- America - A Diversity of Life Styles.
- Kinase Inhibition with BAY 43–9006 in Renal Cell Carcinoma